ADVERTISEMENT
News
AmnioCore - Stability Biologics
08/26/2024
Stability Biologics initiated a 324-patient study to evaluate AmnioCore, Amnio Quad-Core + SoC vs SoC alone in management of DFU and VLU. Primary outcome measures the proportion of pts achieving complete closure at 1-12 weeks. Estimated study completion 8/26. clinicaltrials.gov